(14th May, 2014); Today, the Wellcome Trust has signed a concordat on openness on animal research in the UK. There are 72 other organisations across the scientific sector, including universities, charities, commercial companies, research councils, umbrella bodies and learned societies are joining in concordat.
(22nd May, 2014);The U.S. Food and Drug Administration (FDA) approved the Immucor PreciseType Human Erythrocyte Antigen (HEA) Molecular BeadChip Test (BeadChip Test), manufactured by BioArray Solutions Ltd. of Warren, New Jersey, the first FDA-approved molecular assay used in transfusion medicine to assist in determining blood compatibility. The assay can be used to determine donor and patient non-ABO/non-RhD (non-ABO) red blood cell (RBC) types in the United States.